Høreklinikken Glostrup ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.1% 7.0% 6.4% 7.9% 15.2%  
Credit score (0-100)  28 34 36 30 12  
Credit rating  BB BBB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  11.2 448 177 89.2 0.0  
EBITDA  11.2 448 177 89.2 0.0  
EBIT  11.2 448 177 89.2 0.0  
Pre-tax profit (PTP)  11.1 444.4 169.0 86.5 0.2  
Net earnings  8.5 346.3 130.8 67.1 0.2  
Pre-tax profit without non-rec. items  11.1 444 169 86.5 0.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  48.5 395 226 193 92.8  
Interest-bearing liabilities  0.0 0.0 2.7 11.7 8.0  
Balance sheet total (assets)  268 631 286 210 101  

Net Debt  -140 -546 -143 -115 -28.6  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  11.2 448 177 89.2 0.0  
Gross profit growth  0.0% 3,905.9% -60.5% -49.6% -100.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  268 631 286 210 101  
Balance sheet change%  0.0% 135.7% -54.6% -26.7% -52.0%  
Added value  11.2 448.3 177.1 89.2 0.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.2% 99.7% 38.6% 35.9% 0.1%  
ROI %  23.1% 202.3% 56.8% 41.2% 0.2%  
ROE %  17.5% 156.3% 42.2% 32.1% 0.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  18.1% 62.5% 78.7% 91.7% 92.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1,255.0% -121.9% -80.6% -129.4% -75,181.6%  
Gearing %  0.0% 0.0% 1.2% 6.1% 8.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 603.3% 37.9% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 2.7 4.7 12.1 12.6  
Current Ratio  1.2 2.7 4.7 12.1 12.6  
Cash and cash equivalent  140.4 546.4 145.4 127.1 36.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  48.5 394.8 225.5 192.6 92.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0